My watch list  

656 Current news from israel

matching the following criteria

Flu remedies help combat E. coli bacteria


If the intestinal bacteria level becomes unbalanced, it can cause diseases. Physiologists from the University of Zurich reveal how a specific carbohydrate in the intestinal mucosa heavily multiplies certain E. coli bacteria and thus causes inflammations. These could be treated with flu remedies, ...


image description
FIC Proteins Send Bacteria Into Hibernation


Bacteria do not cease to amaze us with their survival strategies. A research team from the University of Basel's Biozentrum has now discovered how bacteria enter a sleep mode using a so-called FIC toxin. In the current issue of “Cell Reports”, the scientists describe the mechanism of action and ...


Divide and rule: a tumour's strategy


Researchers have discovered how aggressive cells can invade healthy tissue during the earliest stage of tumour development. This opens up new ways of attacking cancer at its root. When normal body cells escape the control from their peers, a tumour can form and eventually lead to cancer. ...


image description
How lipids are flipped


A team of researchers at ETH Zurich and the University of Bern has succeeded in determining the structure of a lipid flippase at high resolution, which has provided insight into how this membrane protein transports lipids by flipping. Biological membranes have a fundamental role, countless vital ...


Vifor Fresenius Medical Care Renal Pharma and Relypsa enter into partnership to commercialize Patiromer FOS


Vifor Fresenius Medical Care Renal Pharma Ltd. announced they have entered into an exclusive partnership to commercialize Patiromer for Oral Suspension (Patiromer FOS), Relypsa's investigational medicine for the treatment of hyperkalemia. Under the terms of the agreement, Relypsa will receive an ...


New details of the transmission of stimuli in living organisms unveiled


Researchers unveil new details of how cells in a living organism process stimuli. So-called G-proteins, which help conduct external stimuli that reach a cell into its interior, play a central role here. For the first time, the study shows which parts of the G-proteins are vital for their ...


PNAS Paper Details Efficacy of a Potent, Fully Human Antibody for the Treatment of MERS


Humabs BioMed SA announced that Proceedings of the National Academy of Sciences (PNAS) has published a paper describing the isolation and characterization of a potent antibody from memory B-cells of a patient recovering from an infection with coronavirus (CoV) and the resulting Middle East ...


Merck Serono Awards € 20,000 to Innovation Cup Winners

Merck Serono Innovation Cup 2015 awards novel idea for a new innovative hypoxia activated prodrug approach for the treatment of cancer


Merck Serono announced the winners of the 2015 Innovation Cup – a program that underscores the company’s commitment to developing the next generation of biopharmaceutical talents and discovering promising approaches to new medicines. An oncology team, consisting of PhD and post-doctoral ...


Santhera Announces First Patient Dosing with Omigapil in Congenital Muscular Dystrophy


Santhera Pharmaceuticals announces that the first patient in the CALLISTO Phase I study assessing the pharmacokinetics, safety and tolerability of oral omigapil in patients with Congenital Muscular Dystrophy (CMD) has been dosed and all participating patients have been recruited. This study, ...


Siegfried: German Kartellamt greenlights acquisition of three BASF sites


As announced earlier, Siegfried Group has signed an agreement with BASF of Germany concerning the acquisition of significant segments of that company’s pharmaceutical supply business and connected chemical-pharmaceutical production units in France, Germany and Switzerland. The German antitrust ...


Page 1 From 66
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE